Tamizare por Clamidia y Gonorrea
The authors report that the USPSTF evaluated three randomized clinical trials, all of which found a reduction in the incidence of pelvic inflammatory disease with screening of asymptomatic females for chlamydia. Based on these results, the USPSTF endorsed chlamydia and gonorrhea screening for all sexually active females younger than 25 years and at-risk older women. The authors also report that further studies are needed to evaluate screening in men.
Because dermatologists treat sexually transmitted infections, most commonly herpes simplex virus and human papilloma virus, they have an opportunity to encourage screening for chlamydia and gonorrhea, thereby improving the rate of diagnosis of silent infections and decreasing the morbidity of untreated infections that can lead to pelvic inflammatory disease.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home